Abstract

199: Protective effects of SGLT1/2 inhibitor sotagliflozin on CF-related liver disease in CF rabbits

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call